356 related articles for article (PubMed ID: 22541428)
21. Mitotic defects lead to pervasive aneuploidy and accompany loss of RB1 activity in mouse LmnaDhe dermal fibroblasts.
Pratt CH; Curtain M; Donahue LR; Shopland LS
PLoS One; 2011 Mar; 6(3):e18065. PubMed ID: 21464947
[TBL] [Abstract][Full Text] [Related]
22. Telomere elongation through hTERT immortalization leads to chromosome repositioning in control cells and genomic instability in Hutchinson-Gilford progeria syndrome fibroblasts, expressing a novel SUN1 isoform.
Bikkul MU; Faragher RGA; Worthington G; Meinke P; Kerr ARW; Sammy A; Riyahi K; Horton D; Schirmer EC; Hubank M; Kill IR; Anderson RM; Slijepcevic P; Makarov E; Bridger JM
Genes Chromosomes Cancer; 2019 Jun; 58(6):341-356. PubMed ID: 30474255
[TBL] [Abstract][Full Text] [Related]
23. Embryonic senescence and laminopathies in a progeroid zebrafish model.
Koshimizu E; Imamura S; Qi J; Toure J; Valdez DM; Carr CE; Hanai J; Kishi S
PLoS One; 2011 Mar; 6(3):e17688. PubMed ID: 21479207
[TBL] [Abstract][Full Text] [Related]
24. Absence of progeria-like disease phenotypes in knock-in mice expressing a non-farnesylated version of progerin.
Yang SH; Chang SY; Ren S; Wang Y; Andres DA; Spielmann HP; Fong LG; Young SG
Hum Mol Genet; 2011 Feb; 20(3):436-44. PubMed ID: 21088111
[TBL] [Abstract][Full Text] [Related]
25. Vascular Smooth Muscle-Specific Progerin Expression Accelerates Atherosclerosis and Death in a Mouse Model of Hutchinson-Gilford Progeria Syndrome.
Hamczyk MR; Villa-Bellosta R; Gonzalo P; Andrés-Manzano MJ; Nogales P; Bentzon JF; López-Otín C; Andrés V
Circulation; 2018 Jul; 138(3):266-282. PubMed ID: 29490993
[TBL] [Abstract][Full Text] [Related]
26. Hutchinson-Gilford progeria syndrome through the lens of transcription.
Prokocimer M; Barkan R; Gruenbaum Y
Aging Cell; 2013 Aug; 12(4):533-43. PubMed ID: 23496208
[TBL] [Abstract][Full Text] [Related]
27. Multitissular involvement in a family with LMNA and EMD mutations: Role of digenic mechanism?
Ben Yaou R; Toutain A; Arimura T; Demay L; Massart C; Peccate C; Muchir A; Llense S; Deburgrave N; Leturcq F; Litim KE; Rahmoun-Chiali N; Richard P; Babuty D; Récan-Budiartha D; Bonne G
Neurology; 2007 May; 68(22):1883-94. PubMed ID: 17536044
[TBL] [Abstract][Full Text] [Related]
28. LMNA-associated cardiocutaneous progeria: an inherited autosomal dominant premature aging syndrome with late onset.
Kane MS; Lindsay ME; Judge DP; Barrowman J; Ap Rhys C; Simonson L; Dietz HC; Michaelis S
Am J Med Genet A; 2013 Jul; 161A(7):1599-611. PubMed ID: 23666920
[TBL] [Abstract][Full Text] [Related]
29. Vitamin D receptor signaling improves Hutchinson-Gilford progeria syndrome cellular phenotypes.
Kreienkamp R; Croke M; Neumann MA; Bedia-Diaz G; Graziano S; Dusso A; Dorsett D; Carlberg C; Gonzalo S
Oncotarget; 2016 May; 7(21):30018-31. PubMed ID: 27145372
[TBL] [Abstract][Full Text] [Related]
30. Premature Vascular Aging with Features of Plaque Vulnerability in an Atheroprone Mouse Model of Hutchinson-Gilford Progeria Syndrome with
Nevado RM; Hamczyk MR; Gonzalo P; Andrés-Manzano MJ; Andrés V
Cells; 2020 Oct; 9(10):. PubMed ID: 33049978
[TBL] [Abstract][Full Text] [Related]
31. Lamin A/C-mediated neuromuscular junction defects in Emery-Dreifuss muscular dystrophy.
Méjat A; Decostre V; Li J; Renou L; Kesari A; Hantaï D; Stewart CL; Xiao X; Hoffman E; Bonne G; Misteli T
J Cell Biol; 2009 Jan; 184(1):31-44. PubMed ID: 19124654
[TBL] [Abstract][Full Text] [Related]
32. Cellular stress and AMPK activation as a common mechanism of action linking the effects of metformin and diverse compounds that alleviate accelerated aging defects in Hutchinson-Gilford progeria syndrome.
Finley J
Med Hypotheses; 2018 Sep; 118():151-162. PubMed ID: 30037605
[TBL] [Abstract][Full Text] [Related]
33. Blocking protein farnesyltransferase improves nuclear shape in fibroblasts from humans with progeroid syndromes.
Toth JI; Yang SH; Qiao X; Beigneux AP; Gelb MH; Moulson CL; Miner JH; Young SG; Fong LG
Proc Natl Acad Sci U S A; 2005 Sep; 102(36):12873-8. PubMed ID: 16129834
[TBL] [Abstract][Full Text] [Related]
34. Rapamycin reverses cellular phenotypes and enhances mutant protein clearance in Hutchinson-Gilford progeria syndrome cells.
Cao K; Graziotto JJ; Blair CD; Mazzulli JR; Erdos MR; Krainc D; Collins FS
Sci Transl Med; 2011 Jun; 3(89):89ra58. PubMed ID: 21715679
[TBL] [Abstract][Full Text] [Related]
35. Prelamin A farnesylation and progeroid syndromes.
Young SG; Meta M; Yang SH; Fong LG
J Biol Chem; 2006 Dec; 281(52):39741-5. PubMed ID: 17090536
[TBL] [Abstract][Full Text] [Related]
36. Hutchinson-Gilford Progeria Syndrome: A premature aging disease caused by LMNA gene mutations.
Gonzalo S; Kreienkamp R; Askjaer P
Ageing Res Rev; 2017 Jan; 33():18-29. PubMed ID: 27374873
[TBL] [Abstract][Full Text] [Related]
37. Targeting the phospholipase A2 receptor ameliorates premature aging phenotypes.
Griveau A; Wiel C; Le Calvé B; Ziegler DV; Djebali S; Warnier M; Martin N; Marvel J; Vindrieux D; Bergo MO; Bernard D
Aging Cell; 2018 Dec; 17(6):e12835. PubMed ID: 30216637
[TBL] [Abstract][Full Text] [Related]
38. Emerin deficiency does not exacerbate cardiomyopathy in a murine model of Emery-Dreifuss muscular dystrophy caused by an LMNA gene mutation.
Wada E; Matsumoto K; Susumu N; Kato M; Hayashi YK
J Physiol Sci; 2023 Nov; 73(1):27. PubMed ID: 37940872
[TBL] [Abstract][Full Text] [Related]
39. Dermal fibroblasts in Hutchinson-Gilford progeria syndrome with the lamin A G608G mutation have dysmorphic nuclei and are hypersensitive to heat stress.
Paradisi M; McClintock D; Boguslavsky RL; Pedicelli C; Worman HJ; Djabali K
BMC Cell Biol; 2005 Jun; 6():27. PubMed ID: 15982412
[TBL] [Abstract][Full Text] [Related]
40. Sulforaphane enhances progerin clearance in Hutchinson-Gilford progeria fibroblasts.
Gabriel D; Roedl D; Gordon LB; Djabali K
Aging Cell; 2015 Feb; 14(1):78-91. PubMed ID: 25510262
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
